Sean A. Mc Carthy Cytom X Therapeutics, Inc. (CTMX) insider trading activity

CTMX Quotes by TradingView

Sean A. Mc Carthy is CEO of CytomX Therapeutics, Inc.. Currently has a direct ownership of 987,891 shares of CTMX, which is worth approximately $3.81 Million. The most recent transaction as insider was on Dec 23, 2020, when has been sold 100,000 shares (Common Stock) at a price of $1.13 per share, resulting in proceeds of $113,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 988K
9.34% 3M change
50.17% 12M change
Total Value Held $3.81 Million

Sean A. McCarthy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2020
BUY
Exercise of conversion of derivative security
$113,000 $1.13 p/Share
100,000 Added 32.58%
206,894 Common Stock
Nov 30 2020
BUY
Grant, award, or other acquisition
$5,943 $6.39 p/Share
930 Added 0.86%
106,894 Common Stock
Sep 30 2019
SELL
Bona fide gift
-
4,500 Reduced 36.56%
7,809 Common Stock
SAM

Sean A. Mc Carthy

CEO
South San Francisco, CA

Track Institutional and Insider Activities on CTMX

Follow CytomX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTMX shares.

Notify only if

Insider Trading

Get notified when an Cytom X Therapeutics, Inc. insider buys or sells CTMX shares.

Notify only if

News

Receive news related to CytomX Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTMX